COMPUTEX
31.5.2021 08:31:06 CEST | Business Wire | Press release
COMPUTEX kicked off this year’s month-long #COMPUTEXVirtual on May 31 with James Huang, TAITRA Chairman, highlighting the not-to-be-missed events. Michelle Johnston Holthaus, Intel Executive Vice President, Chief Revenue Officer, discussed accelerating digital transformation and how to release a new era of innovation when the world is most looking forward to innovation. On the same day, Arm CEO Simon Segars discussed the role of technology in the post-pandemic. Using examples from Arm's ecosystem partners, Segars demonstrated how technology could be a remarkable force for good that will be critical to the world’s recovery and create a more sustainable and secure future. Breaking away from traditions, COMPUTEX 2021 Virtual is an all-virtual exhibition, using AI platforms and leading the way to create a prosperous technology ecosystem.
“COMPUTEX was born in the 1980s when the technology industry took off. At that time, together with entrepreneurs from around the world, Taiwan pursued disruptive innovation and created an industry supply chain that paved the way for the Internet and digital economy that we have today. It has been one year into the pandemic, and we continue to push forward with innovation and navigate in the new normal. As Taiwan stands at the center of the global technology ecosystem, we will never cease to build, connect, integrate, innovate, and push forward with the latest technologies. Today, I am honored to announce the opening of #COMPUTEXVirtual. No matter where we are, let COMPUTEX connect us for a better future,” said James Huang, TAITRA Chairman.
COMPUTEX 2021 Opening Keynote by Intel is led by Executive Vice President and Chief Revenue Officer Michelle Johnston Holthaus with the theme of "Innovation Unleashed". Intel talks about sustainability awareness of enterprises under the raging global pandemic and how we continue to work with global partners to promote digital transformation; Intel not only response to the global market demand quickly and flexibly with the IDM 2.0 business model, but it also continues to promote innovation with 5G and its Open Architecture. We will also unveil new products leading in performance and enrich people’s user experience.
Arm CEO Simon Segars’ keynote titled “Sparking the World’s Post-Pandemic Recovery” demonstrated how technology can be a remarkable force for good that will be critical to the world’s recovery and create a more sustainable and secure future. The combination of computing in the age of AI will accelerate how we tackle complex challenges surrounding climate change, security, and equitable access to technologies and connectivity. Segars indicated that long-term investments in research and development are the key to shaping that future. Arm has invested significant resources in its next-generation architecture. Armv9 will enable partners to solve hard problems in the next decade of compute related to security, compute efficiency, and AI-enabled services, all while fighting climate change at the same time.
A Variety of Events for an All-New Virtual Experience
COMPUTEX 2021 Virtual offers live demonstration of the latest solutions on 5G, AI & IoT, Edge Computing, High-Performance Computing (HPC), Gaming, and Innovations and Startups.
The month-long online exhibition also includes a variety of events, including the #COMPUTEXVirtual online exhibition, COMPUTEX CEO Keynote, COMPUTEX Keynote, COMPUTEX & InnoVEX Forum, and COMPUTEX Matchmaking, giving attendees direct access to the leading tech manufacturers and the latest technology trends. The exhibition also enables the exhibitors to effectively seize business opportunities through the online matchmaking platform.
The #COMPUTEXVirtual online exhibition features Tech Insights, Virtual Displays, Matchmaking and Networking, and Hyper-Personalized Recommendations. #InnoVEXVirtual, the exclusive exhibit for startups, offers vibrant synergy on the other hand. #COMPUTEXVirtual is now open until June 30 midnight. Register now for free at: https://virtual.computextaipei.com.tw/
For more updates:
COMPUTEX website: https://www.computextaipei.com.tw/
InnoVEX website : https://www.innovex.com.tw/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual:
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX, Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnoVEXVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210530005044/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom